The Associtation between Methylenetetrahydrofolate Reductase Gene Polymorphisms and a Risk of Spontaneously Aborted Embryos

Methylenetetrahydrofolate Reductase(MTHFR) 유전자다형과 자연 유산아 발생의 관련성에 관한 연구

  • Jeon, Nick-Beom (Department of Gynecology & Obstetrics, College of Medicine, Pochon CHA University) ;
  • Ji, Seung Il (Institute for Clinical Research, College of Medicine, Pochon CHA University) ;
  • Shin, Seung Joo (Department of Gynecology & Obstetrics, College of Medicine, Pochon CHA University) ;
  • Cha, Sun Hee (Department of Gynecology & Obstetrics, College of Medicine, Pochon CHA University) ;
  • Choi, Dong Hee (Department of Gynecology & Obstetrics, College of Medicine, Pochon CHA University) ;
  • Yim, Dong Jin (Institute for Clinical Research, College of Medicine, Pochon CHA University) ;
  • Park, Sang Hee (Genetics Lab. of Infertility Medical Center, CHA General Hospital) ;
  • Lee, Suman (Functional Genomics Lab. of CHA Research Institute, College of Medicine, Pochon CHA University) ;
  • Lee, Sang Hwa (Functional Genomics Lab. of CHA Research Institute, College of Medicine, Pochon CHA University) ;
  • Ko, Jung Jae (Institute for Clinical Research, College of Medicine, Pochon CHA University) ;
  • Kim, Nam Keun (Institute for Clinical Research, College of Medicine, Pochon CHA University)
  • 전익범 (포천중문의과대학교 분당차병원 산부인과학교실) ;
  • 지승일 (포천중문의과대학교 분당차병원 임상의학연구소) ;
  • 신승주 (포천중문의과대학교 분당차병원 산부인과학교실) ;
  • 차선희 (포천중문의과대학교 분당차병원 산부인과학교실) ;
  • 최동희 (포천중문의과대학교 분당차병원 산부인과학교실) ;
  • 임동진 (포천중문의과대학교 분당차병원 임상의학연구소) ;
  • 박상희 (강남차병원 유전학교실) ;
  • 이수만 (포천중문의과대학교 분당차병원 차중앙연구소) ;
  • 이상화 (포천중문의과대학교 분당차병원 차중앙연구소) ;
  • 고정재 (포천중문의과대학교 분당차병원 임상의학연구소) ;
  • 김남근 (포천중문의과대학교 분당차병원 임상의학연구소)
  • Published : 2006.03.31

Abstract

Objectives : This study was performed to understand the influence of the methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) genotypes on the spontaneously aborted embryos. Methods : DNA was extracted from tissue samples of 95 spontaneously aborted embryos and 100 samples of normal children randomly and 449 samples of normal adults were selected as the controls. MTHFR genotypes were determined by a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. Results : The aborted embryo group had higher frequency of MTHFR 677CC type (p=0.014) and lower 677CT type (p=0.063) than the controlled child group. The frequency of MTHFR 677CT type was drastically lower than that of controlled adult group (p=0.032). In the MTHFR C677T/A1298C combination, 677CC/1298AC genotype of the aborted embryo was significantly higher (p=0.034) than that of controlled child group, but it was not statistically significant in controlled adult group (p=0.063). Conclusion : MTHFR 677CC and MTHFR 677CC/1298AC genotypes may represent genetic markers for the risk of spontaneously aborted embryos at least in Koreans.

목 적: 본 연구는 methylenetetrahydrofolate reductase (MTHFR C677T와 A1298C) 유전자 돌연변이형이 자연유산아 발생의 원인 유전자로 작용하는지에 대해 알아보고자 시도하였다. 연구방법: 95명의 자연유산아 조직과 대조군으로 100명의 정상 소아의 혈액 그리고 449명의 정상 성인의 혈액을 채취하여 DNA를 분리하여 사용하였다. 유전자형은 분리된 DNA를 이용하여 중합효소 연쇄반응과 제한효소 절편다형 분석방법으로 결정하였다. 결 과: 자연유산아 그룹은 소아대조군에서 보다 MTHFR 677CC 형 (p=0.014)은 높게, 677CT형 (p=0.063)은 낮게 나타났다. 성인대조군과의 비교에서도 MTHFR 677CT 형의 빈도는 현저히 낮게 나타났다 (p=0.032). 그리고 MTHFR 677CC/1298AC 조합형 유전자의 경우 소아대조군 (p=0.034)과의 비교에서는 현저히 높은 빈도를 나타냈으나, 성인대조군 (p=0.063)과의 비교에서는 높은 경향성은 있었으나 통계학적으로 유의한 차이는 없었다. 결 론: MTHFR 677CC와 MTHFR 677CC/1298AC 유전자형은 자연유산아 발생의 위험인자일 가능성이 높으며, 지속적인 연구가 요구된다.

Keywords

References

  1. Younis JS, Ohel G, Brenner B, Ben-Ami M. Familial thrombophilia - the scientific rationale for thrombophylaxis in recurrent pregnancy loss- Hum Reprod 1997; 12: 1389-90
  2. Raziel A, Kormberg Y, Fridler S, Schachter M, Sela BA, Ron-El R. Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss. Am J Reprod Immunol 2001; 45: 65-71
  3. Yamada H, Kato EH, Kobashi G, Ebina Y, Shimada S, Sakuragi N, Fujimoto S. Recurrent pregnancy loss: Etiology of thrombophilia. Semin Thromb Hemost 2001;27: 121-9 https://doi.org/10.1055/s-2001-14070
  4. Nelen WLMD, Blom HJ, Steegers EAP, den Heijer M, Eskes TKAB. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta analysis. Fertil Steril 2000; 74: 1196-99
  5. McCully KS. Chemical pathology of homocysteine. Ann Clin Lab Sci 1994; 24: 27-59
  6. Chango A, Boisson F, Barbe F, Quilliot D, Droesch S, Pfister M, et al. The effect of 677C->T and 1298 A ->C mutations on plasma homocysteine and 5, 10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr 2000; 83: 593-6
  7. Loscalzo J. The oxidant stress of hyperhomocysteinemia. J Clin Invest 1996; 98: 5-7
  8. Fodinger M, Wagner OF, Horl WH, Sunder-Plassmann G. Recent insights into the molecular genetics of the homocysteine metabolism. Kidney Int 59 Suppl 2001;78: S238-42
  9. Jakubowski H, Zhang L, Bardeguez A, Aviv A. Homocysteine thiolactone and proteine homocysteinylation in human endothelial cells: implications for athero-sclerosis. Cir Res 2000; 87: 45-57
  10. Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H, et al. Association between polymorphisms of folate and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 2001; 97: 3205-9
  11. Wouters MGAJ, Boers GHJ, Blom HJ, Trijbels FJM, Tomas CMG, Borm GF. Hyperhomocysteinaemia: a risk factorin women with unexplained recurrent early pregnancy loss. Fertil Steril 1993; 60: 820-5
  12. Quere I, Bellet H, Hofet M, Janbon C, Mares P, Gris JC. A women with five consecutive fetal deaths: case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages. Fertil Steril 1998; 68: 152-4
  13. Isotalo PA, Wells GA, Donnelly JG. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet 2000; 67: 986-90
  14. Zetterberg H, Regland B, Palmer M, Ricksten A, Palmqvist L, Rymo L, et al., Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur J Hum Genet 2002; 10: 113-8
  15. Zetterberg H, Zafiropoulos A, Spandidos DA, Rymo L, Blennow K. Gene-gene interaction between fetal MTHFR 677C>T and transcobalamin 776C>G polymorphisms in human spontaneous abortion. Hum Reprod 2003; 18: 1948-50
  16. Kim NK, Nam YS, Lee S, Kim SH, Shin SJ, Chang SW, et al. Polymorphisms of 5,10-Methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) gene in recurrent spontaneous abortion. Kor J Fertil Steril 2002; 29: 215-22
  17. Horie N, Aiba H, Oguro K, Hojo H, Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeted sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 1995; 20: 191-7
  18. Choi YK, Kang MS, Kim NK, Kim SH, Choi DH, Ahn MO, et al. Contribution of thymidylate synthase enhancer region (TSER) polymorphism to total plasma homocysteine levels in Korean patients with recurrent spontaneous abortion. Kor J Fertil Steril 2004; 31: 183-90
  19. Van der Molen EF, Arends GE, Nelen EL, van der Put NJ, Heil SG, Eskes TK, Blom HJ. A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy. Am J Obstet Gynecol 2000; 182: 1258-63
  20. Kluijtmans LA, Boers GH, Verbruggen B, Trijbels FJ, Novakova IR, Blom HJ. Homozygous cystathionine beta-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis. Blood 1998; 91: 2015-8
  21. Eskes TK. Homocysteine and human reproduction. Clin Exp Obstet Gynecol 2000; 27: 157-67
  22. Yates Z, Lucock M. Interaction between common folate polymorphisms and B-vitamin nutritional status modulates homocysteine and risk for a thrombotic event. Mol Genet Metab 2003; 79: 201-13
  23. Nelen WL, Steegers EA, Eskes TK, Blom HJ. Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet 1997; 350: 861
  24. Holmes ZR, Regan L, Chilcott I, Cohen H. The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss. British J Haematol 1999; 105: 98-101
  25. Lissak A, Sharon A, Fruchter 0, Kassel A, Sanderovitz, Abramovici H. Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss. Am J Obstet Gynecol 1999; 181: 126-30
  26. Grandone E. Methylenetetrahydrofolate reductase (MTHFR) 677T ->C mutation and unexplained early pregnancy loss. Thromb Haemost 1998; 79: 1056-7
  27. Murphy RP, Donoghue C, Nallen RJ, D'Mello M, Regan C, Whitehead AS, et al. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphism in pregnancy. Artherioscler Thromb Vasc Biol 1999; 20: 266-70
  28. Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T, et al. Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod 2000; 15: 458-62
  29. Kutteh WH, Park VM, Deither SR. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril 1999; 71: 1048-53
  30. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 1999; 82: 6-9
  31. Van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural tube defects- Am J Hum Genet 1998; 62: 1044-51
  32. Gebhardt GS, Scholtz CL, Hillermann R, Odendaal HJ. Combined heterozygosity for methylenetetrahydrofolate reductase (MTHFR) mutations C677T and A1298C is associated with abruptio placenta but not with intrauterine growth restriction. Eur J Obstet Gynecol Reprod Biol 2001; 97: 174-7
  33. Zetterberg H. Methylenetetrahydrofolate and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications. Reprod Biol Endocrinol 2004; 2: 7